Those with BMI of 35 and a comorbidity could be prescribed tirzepatide and Nice says it is more effective than Wegovy
The medical treatment regulator for England has approved a second drug to combat obesity, giving patients and doctors what it says is a more effective alternative to semaglutide.
The National Institute for Health and Care Excellence (Nice) issued draft guidance on Tuesday recommending that very obese people should be prescribed tirzepatide, which is marketed in the UK as Mounjaro.
About Author
More Stories
Revealed: Chinese researchers can access half a million UK GP records
Teenagers who go to bed early and sleep longer have sharper brains, study finds
‘I did things I cringe at’: Alex Warren, rough-sleeper, viral prankster and now No 1 pop sensation